● Recruiting

The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study

Condition: Hemodynamics · Sponsor: Peking University Shenzhen Hospital

PhaseNA

Planned participants99

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

The aim of this study was to compare the effect-site target concentration (including EC₅₀ and EC₉₀) of remifentanil required to suppress cardiovascular responses to tracheal intubation during anesthesia induction with etomidate combined with either lidocaine or sufentanil.

This description comes directly from the study's public registry record.

Talk to the study team

zhencong jiang · +8613148861770 · jzcmichael@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07089173